Turnstone Biologics Corp.

The momentum for this stock is not very good. Turnstone Biologics Corp. is not very popular among insiders. Tradey thinks it is not wise to invest in Turnstone Biologics Corp..

News

Turnstone Biologics Corp. (NASDAQ:TSBX) Sees Large Growth in Short Interest

Zolmax Turnstone Biologics Corp. (NASDAQ:TSBX - Get Free Report) saw a significant increase in short interest in August. As of August 15th, there was short interest totalling 209,900 shares, an increase of...\n more…

Comparing Turnstone Biologics (NASDAQ:TSBX) and Tourmaline Bio (NASDAQ:TRML)

Ticker Report Tourmaline Bio (NASDAQ:TRML - Get Free Report) and Turnstone Biologics (NASDAQ:TSBX - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the...\n more…

Turnstone Biologics (NASDAQ:TSBX) PT Lowered to $3.75

Zolmax Turnstone Biologics (NASDAQ:TSBX - Get Free Report) had its price target reduced by research analysts at Piper Sandler from $20.00 to $3.75 in a report released on Monday, Benzinga reports. The firm...\n more…

Turnstone Biologics (NASDAQ:TSBX) PT Lowered to $10.00

Ticker Report Turnstone Biologics (NASDAQ:TSBX - Get Free Report) had its target price reduced by investment analysts at Bank of America from $12.00 to $10.00 in a report issued on Monday, Benzinga reports. The...\n more…

Turnstone Biologics (NASDAQ:TSBX) Given New $3.75 Price Target at Piper Sandler

Ticker Report Turnstone Biologics (NASDAQ:TSBX - Free Report) had its target price lowered by Piper Sandler from $20.00 to $3.75 in a research note issued to investors on Monday, Benzinga reports. Piper Sandler...\n more…

Turnstone Biologics price target lowered by $2 at BofA, here's why

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…